Research and Markets: EpiCast Report: Human Immunodeficiency Virus (HIV) Epidemiology Forecast to 2023

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/f5nvtr/epicast_report) has announced the addition of the "EpiCast Report: Human Immunodeficiency Virus (HIV) - Epidemiology Forecast to 2023" report to their offering.

In 2013, there were 3,394,507 total prevalent cases of HIV in the 8MM, with 1,218,323 cases in the US and 641,500 in the 5EU markets combined. Japan had 18,428 20-year diagnosed prevalent cases of HIV in 2013. Epidemiologists forecast that the total prevalent cases of HIV in the 8MM will increase to 4,126,502 in the 8MM by 2023. Additionally, epidemiologists forecast that the 20-year diagnosed prevalent cases of HIV in Japan will increase to 27,264 cases by 2023.

The total prevalent cases of HIV were segmented by age and sex using country-specific data, whenever available; when data were not available, appropriate proxies were used. For Japan, epidemiologists provide an alternative forecast for the 20-year diagnosed prevalent cases of HIV, which better aligns with the ART market sales data after consolidation. Epidemiologists also provide an alternative forecast for Japan, based on the reported HIV prevalent cases.

Scope

- The HIV EpiCast Report provides an overview of the risk factors, comorbidities, and global trends for HIV in the nine major markets (9MM) (US, France, Germany, Italy, Spain, UK, Japan, Brazil, and China). It includes a 10-year epidemiological forecast of the total prevalent cases of HIV segmented by sex and age (beginning at 0 years and ending at =85 years) in the 8MM, excluding Japan, for which 20-year diagnosed prevalent cases, is forecast. In addition, the report provides the prevalent cases of HIV-positive pregnant women in the total prevalent HIV cases, as well as the total prevalent cases treated by antiretroviral drugs.

- The HIV epidemiology report is written and developed by Masters- and PhD-level epidemiologists.

- The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 9MM.

Key Topics Covered:

1 Tables & Figures

2 Introduction

3 Epidemiology

3.1 Disease Background

3.2 Risk Factors and Comorbidities

3.3 Global Trends

3.4 Forecast Methodology

3.5 Epidemiological Forecast for HIV in the 8MM (2013-2023)

3.6 Epidemiological Forecast for HIV in Japan (2013-2023)

3.7 Discussion

4 Appendix

For more information visit http://www.researchandmarkets.com/research/f5nvtr/epicast_report

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Infectious Diseases

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Infectious Diseases